Andy Evans

Sansanima are developing in vitro, cell-based assay technologies for the replacement of animal testing in the manufacture of clostridial neurotoxin-based medical products.

We provide a cloud platform to enable investors, land managers, farmers, ecologists and citizen scientists to better understand changes to biodiversity. Using audio files and Machine Learning, Wilder Sensing provides details of whats present on a site and, over time, helps understand changes to biodiversity.

Hero of Health - digital solution to chronic disease reversal through building healthy aging communities.

GitLife Biotech has launched www.CellRepo.com, the version control system for synthetic biology, alongside a suite of DNA-based biosecurity tools. Our technologies enable reproducibility and proof of ownership, facilitating scale in synthetic biology. To tie the VCS to the engineered asset we must mark the genome of the biological asset itself. To do so we have developed DNA barcodes to an unprecedented level of sophistication: creating biosecurity tools with varying levels of confidentiality and indelibility. Our protocols cover 90% of the strains used in engineering biology and we are developing more all the time. See www.CellRepo.com for more information and to register. We are a Newcastle University spin out, co-founded with the venture builder Cambridge Future Tech Ltd. We maintain laboratories and offices in both Newcastle and Cambridge, UK.

Atelerix has a transformative technology for the storage and transport of viable cells at room temperature, overcoming the barriers and limitations presented by the current need for cryo-shipping. We use alginate hydrogels to encapsulate biological products, protecting them from biochemical and physical damage during storage and shipment. We can hold cells and tissues at room temperature for up to two weeks, effectively placing them into a state of hibernation - just like the African pygmy hedgehog, genus Atelerix!

Ferrio provides a hub for all your business data, connecting and integrating apps, automating process, and getting real time data into dashboards and reports.

RavenApps Grids allows you to combine data from multiple objects into one editable, spreadsheet-style work place so you can increase your teams’ productivity, improve data quality, and accelerate Salesforce adoption. DRIVE PRODUCTIVITY - Improve your teams productivity by creating smart grid solutions which reduce the clicks they need to complete their work. DRIVE ADOPTION - Give your users the data they need where they need it to drive Salesforce adoption and remove the need for offline spreadsheets. DRIVE YOUR BUSINESS PROCESS - Empower your teams to have the solutions they need with flexible low code grids all using the latest lightning frameworks Grids by RavenApps allow you to: • Display multi object girds • Inline edit • Mass delete • Download • Filtering • Search • Multi Sort • Summarise • And many more actions

Worlds largest AI library for biology

Turn machine data into actionable insight - fast. FourJaw technology turns live machine data into clear, usable insights, empowering better decisions across every shift, every site and every machine. Not just when a machine stops, but where energy’s being wasted, where jobs are stalling and where time and capacity slip away. FourJaw’s plug-and-play IoT hardware connects to almost any machine. It’s installed in minutes with no disruption and no downtime. Real-time insights into performance, energy, and output, all in one intuitive platform, with configurable dashboards that show the data manufacturers need, how they need it, making reporting and analysis feel effortless. See what’s underperforming, what needs improving, and where to act next. From one machine to the entire factory, it’s simple to install and built to scale. FourJaw. Factory Intelligence. Made Simple.

Researchers around the world are looking at better ways to diagnose and treat rare cancers. Today there are 740 global life sciences companies investing in 950 products that include a rare cancer target. This translates into an accelerating number of clinical trials taking place, all requiring access to consenting patients, secure data, and bio-samples. If not readily available to researchers, desperately needed progress in this area becomes at-risk. RareCan offers a rich source of valuable information to researchers, providing rapid, joined up access to patients, data and bio-samples. We represent an unparalleled opportunity to accelerate research into rare cancers now and in the future. By connecting consenting patients with leading researchers, RareCan is pioneering a new platform of a large and growing patient community with a BioResource, giving researchers access to tissue and blood samples, as well as genetic data, to improve the prevention, diagnosis or treatment of rare cancers. This reduces the time taken to provide samples for research purposes from months to weeks. The platform enables researchers to find the exact patients or tissue needed for their rare cancer targets. This means RareCan can build precise cohorts of trial participants, and enable the delivery of histology-independent trials, targeting genetic mutations common across a range of different rare cancers, including solid tumour types associated with cancers such as breast, colorectal and pancreatic. RareCan is the first and only company in the market to bring together ‘consent to contact’ patient recruitment, an abundance of data to ensure accurate screening, and access to bio-samples and genetics. This is the future of clinical research. RareCan is supported by a network of NHS Trusts, including Newcastle Hospitals NHS Foundation Trust, and patient organisations, including GIST Cancer UK.

Sansanima are developing in vitro, cell-based assay technologies for the replacement of animal testing in the manufacture of clostridial neurotoxin-based medical products.

At Sheffield Angels, we connect successful, exited entrepreneurs with early-stage startups seeking more than just capital. Sheffield Angels is built on the belief that the best investors are those who’ve been there and done it — founders who’ve scaled businesses, navigated challenges, and exited successfully. That’s why we bring together experienced operators who offer not only funding, but also hands-on guidance, insight, and a deep understanding of what it takes to build and grow a business. Whether you’re an ambitious founder or a seasoned entrepreneur looking to give back and invest in the next wave of innovation, Sheffield Angels is the place where expertise meets opportunity. Invest smart. Build together. Grow Sheffield. www.sheffieldangels.org

We provide a cloud platform to enable investors, land managers, farmers, ecologists and citizen scientists to better understand changes to biodiversity. Using audio files and Machine Learning, Wilder Sensing provides details of whats present on a site and, over time, helps understand changes to biodiversity.

Hero of Health - digital solution to chronic disease reversal through building healthy aging communities.

GitLife Biotech has launched www.CellRepo.com, the version control system for synthetic biology, alongside a suite of DNA-based biosecurity tools. Our technologies enable reproducibility and proof of ownership, facilitating scale in synthetic biology. To tie the VCS to the engineered asset we must mark the genome of the biological asset itself. To do so we have developed DNA barcodes to an unprecedented level of sophistication: creating biosecurity tools with varying levels of confidentiality and indelibility. Our protocols cover 90% of the strains used in engineering biology and we are developing more all the time. See www.CellRepo.com for more information and to register. We are a Newcastle University spin out, co-founded with the venture builder Cambridge Future Tech Ltd. We maintain laboratories and offices in both Newcastle and Cambridge, UK.